News Related to Sonoma Biotherapeutics

Related coverage linked through entity extraction aliases.

Vie Ventures Names Jeff Bluestone, PhD, as Managing Director

Feb 19, 2026

Vie Ventures, a life sciences venture capital firm focused on autoimmune and immune-mediated diseases, announced that Jeff Bluestone, PhD, has been named Managing Director, joining founders Steven St. Peter, MD, and Luke Evnin, PhD.

Regulatory T Cell Therapies Advance for Autoimmune Diseases and Transplant Rejection

Feb 13, 2026

Engineered regulatory T cell therapies are progressing through clinical trials for autoimmune diseases and organ transplant rejection, with CAR-Treg candidates showing promising early results in rheumatoid arthritis and other conditions.